Took a bunch of high schooldrama kids at a Ground Zero performance and did a surprise music number
Genre: Funny Videos
by: ryantooth
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that the interim safety and efficacy results from the first 20 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 data. Additionally, extended Phase 1 survival data was reported. To view Multimedia News Release go to http://www.prnewswire.com/mnr/pvct/37429/
Genre: News Videos
by: comments
H1 2008 headline results Revenue Up 10.4% to £445.6m (£403.5m) Adjusted group operating profit* Up 11.4% to £90.2m (£81.0m) Earnings Per Share (adjusted)** Up 15.0% to 30.1p (26.2p) Dividend Per Share Up 15.7% to 5.6p (4.84p) Profits at UBM's four technology businesses up 29% to £21.1m, margins exceed 20% CMPMedica turnaround ahead of plan; profits up 44% to £17.3m CMP Asia delivers strong profit growth of 30% to £9.5m Four market-focused businesses created from CMP Information PR Newswire increases investment in customer service systems & emerging economies Commonwealth integrated OAG successfully; RISI performing strongly Events, business information & news distribution generate 85% of H1 profits UBM margin maintained at over 20% Acquisitions performing ahead of UBM's 8% post-tax cost of capital threshold Strong balance sheet; net debt of £181.1m at 30 June Strong cash generation – cash conversion up to 91% from 81% * Adjusted group operating profit is group ...
Alex Arthur survived a late knockdown to retain his interim WBO super featherweight title after an amazing scrap against Stephen Foster jr.
by: balloonx
The host talk about UFC 106 and the rematch of Forrest Griffin and Tito Ortiz. Also sources are saying that Brock Lesnar is apparently very ill, and they might have to have an interim belt. Plus NFL, NBA, and NCAA sports Distributed by Tubemogul.
Genre: Sports Videos
by: UncutSportsShow
Spherix Incorporated (NASDAQ CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced positive interim Phase 3 clinical results for the planned review of the NEET (Naturlose (D-tagatose) Efficacy Evaluation Trial) trial of D-tagatose in drug naïve patients.To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/spherix/40911/
Despite treatment efforts, chronic pain management is failing one in three patients suffering from severe chronic pain, and three in five patients feel moderately or extremely anxious or depressed as a result of their pain. Whilst eight in ten chronic pain patients are taking prescription medication, one in two of these patients are suffering the additional burden of side effects. These are the findings released today from the interim data from PainSTORY (Pain Study Tracking Ongoing Responses for Year), the first survey of its kind to provide in-depth insight into how chronic pain impacts the lives of patients over one year in 13 European countries. To view Multimedia News Release, go to http://www.prnewswire.com/mnr/painstory/35407/
The impact of the recession on the housing market has been well documented, but now the rental market is being hit as well. Rental prices in the UK dropped dramatically in the last quarter, by as much as 6% in some areas, as the knock-on effect of falling house prices and low interest rates sparked a market saturation of properties to let. This has led to UK properties being increasingly managed by a new type of landlord- individuals who are worryingly unaware of the processes involved – and they’re being dubbed the ‘unplandlord’. This new type of homeowner has turned to renting as an interim solution while they hope the property market returns to previous levels. In this video Sarah Beeny has advice for any ‘unplandlords’ including how to find tenants, administration issues and management of the property. For more information landlords can download the Gumtree Guide to the Unplandlord now, and listen to advice from Sarah Beeny at www.gumtree.com/rentalindex.
Genre: How-to
by: RadioLynxContent
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has announced interim data from the first 40 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma. PV-10 treatment was well tolerated and caused selective tumor destruction in the majority of subjects. Additional data on untreated tumors corroborated observations of a possible bystander effect seen during earlier Phase 1 testing. These data were presented today at the American Society of Clinical Oncology 2009 Annual Meeting, Abstract #9060, entitled “Chemoablation of melanoma with intralesional rose bengal (PV-10), in the General Poster Session.To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pvct/37868/